Tuberc Respir Dis > Volume 23(4); 1976 > Article
Tuberculosis and Respiratory Diseases 1976;23(4):194-197.
DOI: https://doi.org/10.4046/trd.1976.23.4.194    Published online December 1, 1976.
Inhibitory Effect in Vitro of Commercial Products of Antituberculosis Agents on the Growth of Tubercle Bacilli
Kyu Jeong Lee, Sung Chin Kim
Korean Institute of Tuberculosis, Korean National Tuberculosis Association
시판 항결핵제의 결핵균에 대한 항균력 실험
이규정, 김성진
Abstract
Three antituberculosis agents commercially available, isoniazid, streptomycin, and p-aminosalicylic acid (PAS) were tested for antituberculosis activity. Nine samples of isoniazid, six samples of streptomycin, and three samples of PAS were tested and compared for inhibitory effect of Mycobacterium tuberculosis. Test results obtained are as follows. 1. Most isoniazid samples showed mininal inhibitory concentration ranging from 0.05μ g to 0 .2μ g. 2. Streptomycin and PAS samples showed minimal inhibitory concentration ranging from 2.5μg to 10μg and from 0.4μg to 1μg respectively. Antibacterial activity obtained from the test results when compared with the known standard drug sample showed that the drug samples tested yielded corresponding values as those quoted for the standard.


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next